Marsh & McLennan Companies, Inc. vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.59 (market cap $94.46M). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 892.5× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Marsh & McLennan Companies, Inc. pays a 2.24% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marsh & McLennan Companies, Inc. for 109 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.
| MRSH | MSTZ | |
|---|---|---|
Market Cap | $84.31B | $94.46M |
Volume | 3,948,947 | 104,717,733 |
Sector | Financials | Leveraged / Inverse |
52-Week High | $207.02 | $27.92 |
52-Week Low | $157.32 | $2.29 |
Typical Hold Time | 109 Days | 8 Days |
Enterprise Value | $104.99B | — |
Dividend Yield | 2.24% | — |
Signals from Pluang's Aura AI — not financial advice
Marsh (MRSH) trades at $175.76, up 1.21% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The stock is supported by robust fundamentals, including a 25.72% ROE and 14.24% net income margin, alongside the recent acquisition of Accel Holdings announced on October 2, 2026. Revenue has grown steadily, reaching $27.0B in 2025, though profit margins have slightly softened.
The outlook remains positive with a consensus price target of $202.71, implying 15% upside, but risks include high valuation multiples and competitive pressures. Analysts are predominantly neutral, with 65% hold ratings, suggesting cautious optimism amid solid operational performance.
MSTZ trades at $2.62, down 1.5% today, with technical indicators showing a bearish bias as moving averages signal selling pressure while oscillators remain neutral. The stock faces resistance at $3 with support at $2, indicating a tight trading range. Recent ETF coverage highlights its inclusion in leveraged fund discussions, though specific company fundamentals remain undisclosed in available data.
The outlook for MSTZ hinges on upcoming financial disclosures to clarify valuation metrics like P/E and profitability. Key risks include limited public financial data and market volatility. Investors await earnings reports to assess growth potential amid current technical weakness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →